chr5-112840851-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000038.6(APC):āc.5257G>Cā(p.Ala1753Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000118 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000038.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APC | ENST00000257430.9 | c.5257G>C | p.Ala1753Pro | missense_variant | Exon 16 of 16 | 5 | NM_000038.6 | ENSP00000257430.4 | ||
ENSG00000258864 | ENST00000520401.1 | n.228+11879G>C | intron_variant | Intron 3 of 7 | 3 | ENSP00000454861.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250566Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135506
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461822Hom.: 0 Cov.: 63 AF XY: 0.00000825 AC XY: 6AN XY: 727214
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Uncertain:3
This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 1753 of the APC protein (p.Ala1753Pro). This variant is present in population databases (rs587781350, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of APC-related conditions (PMID: 32829589, 34754157, 36243179). ClinVar contains an entry for this variant (Variation ID: 140893). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt APC protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 1753 of the APC protein (p.Ala1753Pro). This variant is present in population databases (rs587781350, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of APC-related conditions (PMID: 32829589, 34754157). ClinVar contains an entry for this variant (Variation ID: 140893).Computational prediction suggests that this variant may not impact protein structure and function. Splice site prediction tools suggest that this variant may not impact RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:2Benign:1
- -
This missense variant replaces alanine with proline at codon 1753 of the APC protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in individuals affected with Familial adenomatous polyposis (PMID: 32829589) but co-occurs with another APC variant with a demonstrated splicing defect. This variant has been identified in 6/281968 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Classic or attenuated familial adenomatous polyposis Uncertain:1
This missense variant replaces alanine with proline at codon 1753 of the APC protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in individuals affected with Familial adenomatous polyposis (PMID: 32829589) but co-occurs with another APC variant with a demonstrated splicing defect. This variant has been identified in 6/281968 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at